Investigating the Prevalence of BRCA1 and BRCA2 Gene Mutations in Patients with Breast Cancer
Background: Breast cancer is the most common cancer among women. Genetic is a proven risk factor in this disease. As breast cancer genes (BRCA1 and BRCA2) affect the incidence of this type of cancer, identification of mutation carriers is important in reduction of the overall risk. The purpose of th...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | fas |
Published: |
Vesnu Publications
2013-02-01
|
Series: | مجله دانشکده پزشکی اصفهان |
Online Access: | http://jims.mui.ac.ir/index.php/jims/article/view/2217 |
id |
doaj-e121de6be33b46be99c5df6917b83df3 |
---|---|
record_format |
Article |
spelling |
doaj-e121de6be33b46be99c5df6917b83df32020-11-25T00:44:04ZfasVesnu Publications مجله دانشکده پزشکی اصفهان1027-75951735-854X2013-02-0130218221722241232Investigating the Prevalence of BRCA1 and BRCA2 Gene Mutations in Patients with Breast CancerMohammad Hassan Tajadini0Houra Khadem1Meraj Pourhosein2Ali Mohammad Sabzghabaee3Simin Hemati4Hamid Mirmohammad Sadeghi5MSc Student, Physiology Research Center AND Department of Clinical Biochemistry, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, IranStudent of Pharmacy, School of Pharmacy and Pharmaceutical Sciences AND Student Research Committee, Isfahan University of Medical Sciences, Isfahan, IranAssociate Professor, Department of Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, IranAssociate Professor, Isfahan Clinical Toxicology Research Center, Isfahan University of Medical Sciences, Isfahan, IranAssistant Professor, Department of Radiotherapy and Oncology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, IranProfessor, Department of Biotechnology, School of Pharmacy and Pharmaceutical Sciences AND Physiology Research Center, Isfahan University of Medical Sciences, Isfahan, IranBackground: Breast cancer is the most common cancer among women. Genetic is a proven risk factor in this disease. As breast cancer genes (BRCA1 and BRCA2) affect the incidence of this type of cancer, identification of mutation carriers is important in reduction of the overall risk. The purpose of this study was to determine the prevalence of BRCA1 and BRCA2 mutations in patients with breast cancer using high resolution melting (HRM) analysis. Methods: Blood samples of 41 female patients with breast cancer and 20 healthy women were collected randomly. The studied mutations were 185delAG, 5382insC, 3889delAG and 1476delG in BRCA1 and 6174delT and 6033-34insGT in BRCA2. Genomic DNA was extracted from blood samples. Forward and reverse primers were designed for each mutation. DNA samples of healthy individuals were sequenced to make sure about the absence of the studied mutations. Real-time polymerase chain reaction (PCR) and HRM analysis were performed and HRM and melting curves were plotted for all samples. For each mutation, some random samples were sequenced. The curves in the case and control groups were compared for each mutation. Findings: The desired mutations were not observed in any samples of the case group. Sequenced samples confirmed the HRM results. Conclusion: Due to the low number of samples and lack of known native mutations, observation and identification of mutations seem to be impossible in studies such as the present one. However, this study can serve as a base for extensive and applied studies of native and non-native mutations in Iranian population. Keywords: Breast cancer, BRCA1 gene, BRCA2 gene, High resolution meltinghttp://jims.mui.ac.ir/index.php/jims/article/view/2217 |
collection |
DOAJ |
language |
fas |
format |
Article |
sources |
DOAJ |
author |
Mohammad Hassan Tajadini Houra Khadem Meraj Pourhosein Ali Mohammad Sabzghabaee Simin Hemati Hamid Mirmohammad Sadeghi |
spellingShingle |
Mohammad Hassan Tajadini Houra Khadem Meraj Pourhosein Ali Mohammad Sabzghabaee Simin Hemati Hamid Mirmohammad Sadeghi Investigating the Prevalence of BRCA1 and BRCA2 Gene Mutations in Patients with Breast Cancer مجله دانشکده پزشکی اصفهان |
author_facet |
Mohammad Hassan Tajadini Houra Khadem Meraj Pourhosein Ali Mohammad Sabzghabaee Simin Hemati Hamid Mirmohammad Sadeghi |
author_sort |
Mohammad Hassan Tajadini |
title |
Investigating the Prevalence of BRCA1 and BRCA2 Gene Mutations in Patients with Breast Cancer |
title_short |
Investigating the Prevalence of BRCA1 and BRCA2 Gene Mutations in Patients with Breast Cancer |
title_full |
Investigating the Prevalence of BRCA1 and BRCA2 Gene Mutations in Patients with Breast Cancer |
title_fullStr |
Investigating the Prevalence of BRCA1 and BRCA2 Gene Mutations in Patients with Breast Cancer |
title_full_unstemmed |
Investigating the Prevalence of BRCA1 and BRCA2 Gene Mutations in Patients with Breast Cancer |
title_sort |
investigating the prevalence of brca1 and brca2 gene mutations in patients with breast cancer |
publisher |
Vesnu Publications |
series |
مجله دانشکده پزشکی اصفهان |
issn |
1027-7595 1735-854X |
publishDate |
2013-02-01 |
description |
Background: Breast cancer is the most common cancer among women. Genetic is a proven risk factor in this disease. As breast cancer genes (BRCA1 and BRCA2) affect the incidence of this type of cancer, identification of mutation carriers is important in reduction of the overall risk. The purpose of this study was to determine the prevalence of BRCA1 and BRCA2 mutations in patients with breast cancer using high resolution melting (HRM) analysis.
Methods: Blood samples of 41 female patients with breast cancer and 20 healthy women were collected randomly. The studied mutations were 185delAG, 5382insC, 3889delAG and 1476delG in BRCA1 and 6174delT and 6033-34insGT in BRCA2. Genomic DNA was extracted from blood samples. Forward and reverse primers were designed for each mutation. DNA samples of healthy individuals were sequenced to make sure about the absence of the studied mutations. Real-time polymerase chain reaction (PCR) and HRM analysis were performed and HRM and melting curves were plotted for all samples. For each mutation, some random samples were sequenced. The curves in the case and control groups were compared for each mutation.
Findings: The desired mutations were not observed in any samples of the case group. Sequenced samples confirmed the HRM results.
Conclusion: Due to the low number of samples and lack of known native mutations, observation and identification of mutations seem to be impossible in studies such as the present one. However, this study can serve as a base for extensive and applied studies of native and non-native mutations in Iranian population.
Keywords: Breast cancer, BRCA1 gene, BRCA2 gene, High resolution melting |
url |
http://jims.mui.ac.ir/index.php/jims/article/view/2217 |
work_keys_str_mv |
AT mohammadhassantajadini investigatingtheprevalenceofbrca1andbrca2genemutationsinpatientswithbreastcancer AT hourakhadem investigatingtheprevalenceofbrca1andbrca2genemutationsinpatientswithbreastcancer AT merajpourhosein investigatingtheprevalenceofbrca1andbrca2genemutationsinpatientswithbreastcancer AT alimohammadsabzghabaee investigatingtheprevalenceofbrca1andbrca2genemutationsinpatientswithbreastcancer AT siminhemati investigatingtheprevalenceofbrca1andbrca2genemutationsinpatientswithbreastcancer AT hamidmirmohammadsadeghi investigatingtheprevalenceofbrca1andbrca2genemutationsinpatientswithbreastcancer |
_version_ |
1725276864091521024 |